524828 Stock Overview
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
BDH Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹334.55 |
| 52 Week High | ₹372.05 |
| 52 Week Low | ₹129.00 |
| Beta | 0.36 |
| 1 Month Change | 14.83% |
| 3 Month Change | 41.28% |
| 1 Year Change | 150.88% |
| 3 Year Change | 248.49% |
| 5 Year Change | 355.17% |
| Change since IPO | 9,458.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524828 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 8.1% | 0.8% | 0.5% |
| 1Y | 150.9% | 58.6% | 44.7% |
Return vs Industry: 524828 exceeded the Indian Pharmaceuticals industry which returned 57.7% over the past year.
Return vs Market: 524828 exceeded the Indian Market which returned 44.8% over the past year.
Price Volatility
| 524828 volatility | |
|---|---|
| 524828 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524828's share price has been volatile over the past 3 months.
Volatility Over Time: 524828's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1935 | 116 | Jayashree Nair | www.bdhind.com |
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products.
BDH Industries Limited Fundamentals Summary
| 524828 fundamental statistics | |
|---|---|
| Market cap | ₹1.93b |
| Earnings (TTM) | ₹88.14m |
| Revenue (TTM) | ₹814.44m |
21.9x
P/E Ratio2.4x
P/S RatioIs 524828 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524828 income statement (TTM) | |
|---|---|
| Revenue | ₹814.44m |
| Cost of Revenue | ₹576.59m |
| Gross Profit | ₹237.85m |
| Other Expenses | ₹149.71m |
| Earnings | ₹88.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 15.31 |
| Gross Margin | 29.20% |
| Net Profit Margin | 10.82% |
| Debt/Equity Ratio | 10.8% |
How did 524828 perform over the long term?
See historical performance and comparison